Hepatitis Delta Virus Acts as an Immunogenic Adjuvant in Hepatitis B Virus-Infected Hepatocytes

Hepatitis delta virus (HDV) requires hepatitis B virus (HBV) to complete its infection cycle and causes severe hepatitis, with limited therapeutic options. To determine the prospect of T cell therapy in HBV/HDV co-infection, we study the impact of HDV on viral antigen processing and presentation. Us...

詳細記述

保存先:
書誌詳細
出版年:Cell Rep Med
主要な著者: Tham, Christine Y.L., Kah, Janine, Tan, Anthony T., Volz, Tassilo, Chia, Adeline, Giersch, Katja, Ladiges, Yvonne, Loglio, Alessandro, Borghi, Marta, Sureau, Camille, Lampertico, Pietro, Lütgehetmann, Marc, Dandri, Maura, Bertoletti, Antonio
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7659593/
https://ncbi.nlm.nih.gov/pubmed/33205065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.xcrm.2020.100060
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料